STTK
Shattuck Labs, Inc.
Biotechnology · Healthcare · United States
5.56
close · 2026-10-30
value
29
cheaper than peers29
quality
32
stronger fundamentals32
ranked against
Biotechnology (commercial)
value
quality
162 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 2.65× | 62 |
| cash flow yield, latest year | -7.2% | 57 |
| earnings yield, latest year | -12.6% | 51 |
| cash flow yield, 1 year ago | -10.9% | 48 |
| earnings yield, 1 year ago | -26.8% | 41 |
| cash flow yield, 2 years ago | -14.6% | 38 |
| earnings yield, 2 years ago | -36.9% | 36 |
| earnings yield, 3 years ago | -43.3% | 33 |
| cash flow yield, 3 years ago | -19.0% | 29 |
| price to sales | 558.02× | 6 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 3.0% | 81 |
| return on equity | -61.0% | 40 |
| operating margin | -5258.3% | 4 |
3 of 4 measures available
Facts
| market cap | $558M |
| free cash flow | -$22.4M |
| employees | 40 |
| first trade | 2020-10-09 |
| next earnings | 2026-08-11 |
| fundamentals updated | 2026-08-11 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.70 | -1.49 | -2.05 | -2.41 |
| free cash flow | -$40.0M | -$60.6M | -$81.6M | -$106.1M |
| net income | -$48.8M | -$75.4M | -$87.3M | -$101.9M |
| revenue | $1.0M | $5.7M | $1.7M | $652,000 |